Tema Oncology ETF

Rentabilidade por seis meses: -12.19%
Indústria: Health & Biotech Equities

Regeneron
AstraZeneca PLC
Merck & Co
argenx SE
Daiichi Sankyo Company, Limited
Amgen
Chugai Pharmaceutical Co., Ltd.
Blueprint Medicines Corporation
Illumina
Revolution Medicines, Inc.
Descansar
Regeneron: 6.1%AstraZeneca PLC: 5.9%Merck & Co: 4.3%argenx SE: 4.2%Daiichi Sankyo Company, Limited: 3.8%Amgen: 3.8%Chugai Pharmaceutical Co., Ltd.: 3.6%Blueprint Medicines Corporation: 3.3%Illumina: 3.3%Revolution Medicines, Inc.: 3.1%Descansar: 58.7%Compartilhar compartilhar por empresapt.porti.ru
Baixar SVG
Baixar PNG
Baixar CSV
NomeIndústriaCompartilhar, %P/BVP/SP/EEV/EbitdaRendimento de dividendos
Regeneron Regeneron Healthcare 6.0665 3.71 7.34 24.35 23.78 0.1388
AstraZeneca PLC AstraZeneca PLC Healthcare 5.94354 2.49 1.88 14.45 7.38 1.98
Merck & Co Merck & Co Healthcare 4.26457 7.29 4.56 751.54 40.3 2.82
argenx SE argenx SE Healthcare 4.19048 5.2 17.38 0 -87.37 0
Daiichi Sankyo Company, Limited Daiichi Sankyo Company, Limited Healthcare 3.81885 5.48 5.78 46.09 29.44 1.54
Amgen Amgen Healthcare 3.775 24.53 5.42 22.76 26.16 2.92
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. Healthcare 3.57457 5.41 7.92 27.04 18.68 2.06
Blueprint Medicines Corporation Blueprint Medicines Corporation Healthcare 3.30318 41.19 21.57 15.98 -12.82 0
Illumina Illumina Healthcare 3.27465 3.85 4.86 39.92 -21.83 0
Revolution Medicines, Inc. Revolution Medicines, Inc. Healthcare 3.12948 1.79 282.39 0 -5.57 0
41.3210.0935.9194.211.811.15

Pague pela sua assinatura

Mais funcionalidades e dados para análise de empresas e portfólio estão disponíveis por assinatura